CAS: 1927857-61-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PQR 530 REF: AN-AG01E738CAS: 1927857-61-1 | 98% | 490.00 €~1,243.00 € | Thu 02 May 24 |
 | PQR530 REF: TM-T16567CAS: 1927857-61-1 | 99.78% | 52.00 €~665.00 € | Thu 09 May 24 |
 | PQR 530 REF: 3D-FP162373CAS: 1927857-61-1 | Min. 95% | 147.00 €~821.00 € | Mon 13 May 24 |
Ref: AN-AG01E738
| 5mg | 490.00 € | |
| 10mg | 733.00 € | |
| 25mg | 1,243.00 € |
Estimated delivery in United States, on Thursday 2 May 2024
PQR530
CAS:1927857-61-1
PQR530 is a highly potent dual pan-PI3K/mTORC1/2 inhibitor. PQR530 inhibited protein kinase B (PKB, pSer473) …
Formula:
C18H23F2N7O2
Purity:
99.78%
Color and Shape:
Solid
Molecular weight:
407.42
Ref: TM-T16567
| 1mg | 52.00 € | |
| 5mg | 109.00 € | |
| 10mg | 158.00 € | |
| 25mg | 307.00 € | |
| 50mg | 453.00 € | |
| 100mg | 665.00 € | |
| 1ml*10 (DMSO) | 121.00 € |
Estimated delivery in United States, on Thursday 9 May 2024
PQR 530
CAS:1927857-61-1
Inhibitor of panPI3K/mTOR
Formula:
C18H23F2N7O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
407.42 g/mol
Ref: 3D-FP162373
| 5mg | 147.00 € | |
| 10mg | 210.00 € | |
| 25mg | 406.00 € | |
| 50mg | 576.00 € | |
| 100mg | 821.00 € |
Estimated delivery in United States, on Monday 13 May 2024
